ArticleRSC advances2021
Designing a novel visible-light-driven heterostructure Ni-ZnO/S-g-C
Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 67 citations in OpenAlex.
- Retraction: Construction of a binary S-scheme S-g-CRSC advances · 2026Article
- Empowering wastewater treatment with step scheme heterojunction ternary nanocomposites for photocatalytic degradation of nitrophenol.Scientific reports · 2025Article
- Biogenic Ag-doped ZnO nanostructures induced cytotoxicity in luminal A and triple-negative human breast cancer cells.Nanomedicine (London, England) · 2024Article
- Valorization of Agricultural Waste as a Chemiresistor HPolymers · 2023Article
- Construction of a binary S-scheme S-g-CRSC advances · 2022Article
Corrections and comments
- Expression of concern
- Retracted
Authors and funding
5 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, photocorrosion of ZnO is inhibited by doping Ni in the ZnO nanostructure and electron-hole recombination was solved by forming a heterostructure with S-g-C
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.